{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T02:45:15Z","timestamp":1773801915621,"version":"3.50.1"},"reference-count":214,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T00:00:00Z","timestamp":1773705600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T00:00:00Z","timestamp":1773705600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["RS-2024-00346770"],"award-info":[{"award-number":["RS-2024-00346770"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflamm. Res."],"DOI":"10.1007\/s00011-026-02203-y","type":"journal-article","created":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T11:19:37Z","timestamp":1773746377000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Glucosamine as a regulator of O-GlcNAc signaling: linking metabolism to disease pathogenesis"],"prefix":"10.1007","volume":"75","author":[{"given":"Sang-Min","family":"Kim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chanhaeng","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong Yeol","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Inn-Oc","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,17]]},"reference":[{"key":"2203_CR1","doi-asserted-by":"crossref","unstructured":"Haworth W, Lake W, Peat S. 59. The configuration of glucosamine (chitosamine). J Chem Soc (Resumed) 1939:271\u20134.","DOI":"10.1039\/jr9390000271"},{"key":"2203_CR2","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1097\/01.GME.0000087983.28957.5D","volume":"11","author":"O Bruyere","year":"2004","unstructured":"Bruyere O, Pavelka K, Rovati LC, Deroisy R, Olejarova M, Gatterova J, et al. Glucosamine sulfate reduces osteoarthritis progression in postmenopausal women with knee osteoarthritis: evidence from two 3-year studies. Menopause. 2004;11:138\u201343.","journal-title":"Menopause"},{"key":"2203_CR3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1472-6882-3-2","volume":"3","author":"WJ Van Blitterswijk","year":"2003","unstructured":"Van Blitterswijk WJ, Van De Nes JC, Wuisman PI. Glucosamine and chondroitin sulfate supplementation to treat symptomatic disc degeneration: biochemical rationale and case report. BMC Complement Altern Med. 2003;3:1\u20138.","journal-title":"BMC Complement Altern Med"},{"key":"2203_CR4","doi-asserted-by":"publisher","first-page":"3308","DOI":"10.1016\/S0021-9258(17)43295-9","volume":"259","author":"C-R Torres","year":"1984","unstructured":"Torres C-R, Hart GW. Topography and polypeptide distribution of terminal N-acetylglucosamine residues on the surfaces of intact lymphocytes. Evidence for O-linked GlcNAc. J Biol Chem. 1984;259:3308\u201317.","journal-title":"J Biol Chem"},{"key":"2203_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/ar2274","volume":"9","author":"ML Tiku","year":"2007","unstructured":"Tiku ML, Narla H, Jain M, Yalamanchili P. Glucosamine prevents in vitro collagen degradation in chondrocytes by inhibiting advanced lipoxidation reactions and protein oxidation. Arthritis Res Therapy. 2007;9:1\u201310.","journal-title":"Arthritis Res Therapy"},{"key":"2203_CR6","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1016\/j.lfs.2010.02.015","volume":"86","author":"K Naito","year":"2010","unstructured":"Naito K, Watari T, Furuhata A, Yomogida S, Sakamoto K, Kurosawa H, et al. Evaluation of the effect of glucosamine on an experimental rat osteoarthritis model. Life Sci. 2010;86:538\u201343.","journal-title":"Life Sci"},{"key":"2203_CR7","doi-asserted-by":"publisher","first-page":"10148","DOI":"10.1016\/S0021-9258(18)99202-1","volume":"266","author":"R Traxinger","year":"1991","unstructured":"Traxinger R, Marshall S. Coordinated regulation of glutamine: fructose-6-phosphate amidotransferase activity by insulin, glucose, and glutamine. Role of hexosamine biosynthesis in enzyme regulation. J Biol Chem. 1991;266:10148\u201354.","journal-title":"J Biol Chem"},{"key":"2203_CR8","doi-asserted-by":"publisher","first-page":"30133","DOI":"10.1074\/jbc.M403773200","volume":"279","author":"NE Zachara","year":"2004","unstructured":"Zachara NE, O\u2019Donnell N, Cheung WD, Mercer JJ, Marth JD, Hart GW. Dynamic O-GlcNAc modification of nucleocytoplasmic proteins in response to stress: a survival response of mammalian cells. J Biol Chem. 2004;279:30133\u201342.","journal-title":"J Biol Chem"},{"key":"2203_CR9","doi-asserted-by":"publisher","first-page":"2211","DOI":"10.1074\/jbc.AW119.003226","volume":"294","author":"GW Hart","year":"2019","unstructured":"Hart GW. Nutrient regulation of signaling and transcription. J Biol Chem. 2019;294:2211\u201331.","journal-title":"J Biol Chem"},{"key":"2203_CR10","doi-asserted-by":"publisher","first-page":"9005","DOI":"10.1016\/S0021-9258(19)50380-5","volume":"267","author":"RS Haltiwanger","year":"1992","unstructured":"Haltiwanger RS, Blomberg MA, Hart GW. Glycosylation of nuclear and cytoplasmic proteins. Purification and characterization of a uridine diphospho-N-acetylglucosamine: polypeptide beta-N-acetylglucosaminyltransferase. J Biol Chem. 1992;267:9005\u201313.","journal-title":"J Biol Chem"},{"key":"2203_CR11","doi-asserted-by":"publisher","first-page":"9838","DOI":"10.1074\/jbc.M010420200","volume":"276","author":"Y Gao","year":"2001","unstructured":"Gao Y, Wells L, Comer FI, Parker GJ, Hart GW. Dynamic O-glycosylation of nuclear and cytosolic proteins: cloning and characterization of a neutral, cytosolic \u03b2-N-acetylglucosaminidase from human brain. J Biol Chem. 2001;276:9838\u201345.","journal-title":"J Biol Chem"},{"key":"2203_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3233\/JAD-2006-9101","volume":"9","author":"C-X Gong","year":"2006","unstructured":"Gong C-X, Liu F, Grundke-Iqbal I, Iqbal K. Impaired brain glucose metabolism leads to alzheimer neurofibrillary degeneration through a decrease in Tau O-GlcNAcylation. J Alzheimer\u2019s Disease. 2006;9:1\u201312.","journal-title":"J Alzheimer\u2019s Disease"},{"key":"2203_CR13","doi-asserted-by":"publisher","first-page":"802336","DOI":"10.3389\/fimmu.2022.802336","volume":"13","author":"LK Abramowitz","year":"2022","unstructured":"Abramowitz LK, Hanover JA. Chronically elevated O-GlcNAcylation limits nitric oxide production and deregulates specific pro-inflammatory cytokines. Front Immunol. 2022;13:802336.","journal-title":"Front Immunol"},{"key":"2203_CR14","doi-asserted-by":"publisher","first-page":"12529","DOI":"10.18632\/oncotarget.3725","volume":"6","author":"YR Yang","year":"2015","unstructured":"Yang YR, Kim DH, Seo Y-K, Park D, Jang H-J, Choi SY, et al. Elevated O-GlcNAcylation promotes colonic inflammation and tumorigenesis by modulating NF-\u03baB signaling. Oncotarget. 2015;6:12529.","journal-title":"Oncotarget"},{"key":"2203_CR15","doi-asserted-by":"publisher","first-page":"118180","DOI":"10.1016\/j.biopha.2025.118180","volume":"188","author":"X Chen","year":"2025","unstructured":"Chen X, Zhang G, Qiao Z, Zhang S, Chen L, Wang H, et al. Glucosamine alleviates liver fibrosis through modulation of sinusoidal blood flow and hepatic immune responses. Biomed Pharmacother. 2025;188:118180.","journal-title":"Biomed Pharmacother"},{"key":"2203_CR16","doi-asserted-by":"publisher","first-page":"1562","DOI":"10.2337\/diabetes.48.8.1562","volume":"48","author":"M-E Patti","year":"1999","unstructured":"Patti M-E, Virkam\u00e4ki A, Landaker EJ, Kahn CR, Yki-J\u00e4rvinen H. Activation of the hexosamine pathway by glucosamine in vivo induces insulin resistance of early postreceptor insulin signaling events in skeletal muscle. Diabetes. 1999;48:1562\u201371.","journal-title":"Diabetes"},{"key":"2203_CR17","doi-asserted-by":"publisher","first-page":"C1509","DOI":"10.1152\/ajpcell.00456.2007","volume":"294","author":"V Champattanachai","year":"2008","unstructured":"Champattanachai V, Marchase RB, Chatham JC. Glucosamine protects neonatal cardiomyocytes from ischemia-reperfusion injury via increased protein O-GlcNAc and increased mitochondrial Bcl-2. Am J Physiology-Cell Physiol. 2008;294:C1509\u201320.","journal-title":"Am J Physiology-Cell Physiol"},{"key":"2203_CR18","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1002\/cbin.11783","volume":"46","author":"L Huang","year":"2022","unstructured":"Huang L, Su W, Wu Z, Zheng L, Lv C. Glucosamine suppresses oxidative stress and induces protective autophagy in osteoblasts by blocking the ROS\/Akt\/mTOR signaling pathway. Cell Biol Int. 2022;46:829\u201339.","journal-title":"Cell Biol Int"},{"key":"2203_CR19","doi-asserted-by":"publisher","first-page":"4905","DOI":"10.3390\/ijms25094905","volume":"25","author":"Y-P Hsu","year":"2024","unstructured":"Hsu Y-P, Huang T-H, Liu S-T, Huang S-M, Chen Y-C, Wu C-C. Glucosamine and Silibinin alter cartilage homeostasis through glycosylation and cellular stresses in human chondrocyte cells. Int J Mol Sci. 2024;25:4905.","journal-title":"Int J Mol Sci"},{"key":"2203_CR20","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/1475-2867-14-45","volume":"14","author":"V Chesnokov","year":"2014","unstructured":"Chesnokov V, Gong B, Sun C, Itakura K. Anti-cancer activity of glucosamine through Inhibition of N-linked glycosylation. Cancer Cell Int. 2014;14:45.","journal-title":"Cancer Cell Int"},{"key":"2203_CR21","doi-asserted-by":"publisher","first-page":"29329","DOI":"10.1074\/jbc.M115.674671","volume":"290","author":"M-W Chien","year":"2015","unstructured":"Chien M-W, Lin M-H, Huang S-H, Fu S-H, Hsu C-Y, Yen BL-J, et al. Glucosamine modulates T cell differentiation through down-regulating N-linked glycosylation of CD25. J Biol Chem. 2015;290:29329\u201344.","journal-title":"J Biol Chem"},{"key":"2203_CR22","doi-asserted-by":"publisher","first-page":"E48","DOI":"10.1152\/ajpendo.00275.2016","volume":"312","author":"DR Beriault","year":"2017","unstructured":"Beriault DR, Dang VT, Zhong LH, Petlura CI, McAlpine CS, Shi Y, et al. Glucosamine induces ER stress by disrupting lipid-linked oligosaccharide biosynthesis and N-linked protein glycosylation. Am J Physiology-Endocrinology Metabolism. 2017;312:E48\u201357.","journal-title":"Am J Physiology-Endocrinology Metabolism"},{"key":"2203_CR23","first-page":"471","volume":"78","author":"S Dahmer","year":"2008","unstructured":"Dahmer S, Schiller RM. Glucosamine Am Family Physician. 2008;78:471\u20136.","journal-title":"Glucosamine Am Family Physician"},{"key":"2203_CR24","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1007\/BF02059060","volume":"15","author":"R Lemperg","year":"1974","unstructured":"Lemperg R, Larsson S-E, Hjertquist S-O. The glycosaminoglycans of bovine articular cartilage: I. concentration and distribution in different layers in relation to age. Calcif Tissue Res. 1974;15:237\u201351.","journal-title":"Calcif Tissue Res"},{"key":"2203_CR25","doi-asserted-by":"crossref","unstructured":"Vynios DH. Metabolism of cartilage proteoglycans in health and disease. BioMed Research International. 2014; 2014:452315.","DOI":"10.1155\/2014\/452315"},{"key":"2203_CR26","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1055\/s-0030-1248220","volume":"17","author":"S Owens","year":"2004","unstructured":"Owens S, Wagner P, Vangsness CT. Recent advances in glucosamine and chondroitin supplementation. J Knee Surg. 2004;17:185\u201393.","journal-title":"J Knee Surg"},{"key":"2203_CR27","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1056\/NEJMoa052771","volume":"354","author":"DO Clegg","year":"2006","unstructured":"Clegg DO, Reda DJ, Harris CL, Klein MA, O\u2019Dell JR, Hooper MM, et al. Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis. N Engl J Med. 2006;354:795\u2013808.","journal-title":"N Engl J Med"},{"key":"2203_CR28","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/S0140-6736(00)03610-2","volume":"357","author":"JY Reginster","year":"2001","unstructured":"Reginster JY, Deroisy R, Rovati LC, Lee RL, Lejeune E, Bruyere O, et al. Long-term effects of glucosamine sulphate on osteoarthritis progression: a randomised, placebo-controlled clinical trial. Lancet. 2001;357:251\u20136.","journal-title":"Lancet"},{"key":"2203_CR29","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1185\/03007995.2016.1154521","volume":"32","author":"EJ Kucharz","year":"2016","unstructured":"Kucharz EJ, Kovalenko V, Sz\u00e1nt\u00f3 S, Bruy\u00e8re O, Cooper C, Reginster J-Y. A review of glucosamine for knee osteoarthritis: why patented crystalline glucosamine sulfate should be differentiated from other glucosamines to maximize clinical outcomes. Curr Med Res Opin. 2016;32:997\u20131004.","journal-title":"Curr Med Res Opin"},{"key":"2203_CR30","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.fct.2004.11.006","volume":"43","author":"J Anderson","year":"2005","unstructured":"Anderson J, Nicolosi R, Borzelleca J. Glucosamine effects in humans: a review of effects on glucose metabolism, side effects, safety considerations and efficacy. Food Chem Toxicol. 2005;43:187\u2013201.","journal-title":"Food Chem Toxicol"},{"key":"2203_CR31","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1016\/j.joca.2005.07.009","volume":"13","author":"S Persiani","year":"2005","unstructured":"Persiani S, Roda E, Rovati L, Locatelli M, Giacovelli G, Roda A. Glucosamine oral bioavailability and plasma pharmacokinetics after increasing doses of crystalline glucosamine sulfate in man. Osteoarthr Cartil. 2005;13:1041\u20139.","journal-title":"Osteoarthr Cartil"},{"key":"2203_CR32","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1016\/j.joca.2007.01.019","volume":"15","author":"S Persiani","year":"2007","unstructured":"Persiani S, Rotini R, Trisolino G, Rovati L, Locatelli M, Paganini D, et al. Synovial and plasma glucosamine concentrations in Osteoarthritic patients following oral crystalline glucosamine sulphate at therapeutic dose. Osteoarthr Cartil. 2007;15:764\u201372.","journal-title":"Osteoarthr Cartil"},{"key":"2203_CR33","first-page":"699","volume":"51","author":"I Setnikar","year":"2001","unstructured":"Setnikar I, Rovati LC. Absorption, distribution, metabolism and excretion of glucosamine sulfate. Arzneimittelforschung. 2001;51:699\u2013725.","journal-title":"Arzneimittelforschung"},{"key":"2203_CR34","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1016\/j.joca.2008.01.006","volume":"16","author":"M Meulyzer","year":"2008","unstructured":"Meulyzer M, Vachon P, Beaudry F, Vinardell T, Richard H, Beauchamp G, et al. Comparison of pharmacokinetics of glucosamine and synovial fluid levels following administration of glucosamine sulphate or glucosamine hydrochloride. Osteoarthr Cartil. 2008;16:973\u20139.","journal-title":"Osteoarthr Cartil"},{"key":"2203_CR35","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/S0014-5793(02)03058-2","volume":"524","author":"M Uldry","year":"2002","unstructured":"Uldry M, Ibberson M, Hosokawa M, Thorens B. GLUT2 is a high affinity glucosamine transporter. FEBS Lett. 2002;524:199\u2013203.","journal-title":"FEBS Lett"},{"key":"2203_CR36","doi-asserted-by":"publisher","first-page":"E103","DOI":"10.1152\/ajpendo.2000.278.1.E103","volume":"278","author":"E Heart","year":"2000","unstructured":"Heart E, Choi WS, Sung CK. Glucosamine-induced insulin resistance in 3T3-L1 adipocytes. Am J Physiology-Endocrinology Metabolism. 2000;278:E103\u201312.","journal-title":"Am J Physiology-Endocrinology Metabolism"},{"key":"2203_CR37","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1111\/j.1462-8902.2004.00350.x","volume":"6","author":"C Bailey","year":"2004","unstructured":"Bailey C, Turner S. Glucosamine-induced insulin resistance in L6 muscle cells. Diabetes Obes Metabolism. 2004;6:293\u20138.","journal-title":"Diabetes Obes Metabolism"},{"key":"2203_CR38","doi-asserted-by":"publisher","first-page":"4706","DOI":"10.1016\/S0021-9258(19)67706-9","volume":"266","author":"S Marshall","year":"1991","unstructured":"Marshall S, Bacote V, Traxinger R. Discovery of a metabolic pathway mediating glucose-induced desensitization of the glucose transport system. Role of hexosamine biosynthesis in the induction of insulin resistance. J Biol Chem. 1991;266:4706\u201312.","journal-title":"J Biol Chem"},{"key":"2203_CR39","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.2337\/diabetes.48.5.1101","volume":"48","author":"A Virkam\u00e4ki","year":"1999","unstructured":"Virkam\u00e4ki A, Yki-J\u00e4rvinen H. Allosteric regulation of glycogen synthase and hexokinase by glucosamine-6-phosphate during glucosamine-induced insulin resistance in skeletal muscle and heart. Diabetes. 1999;48:1101\u20137.","journal-title":"Diabetes"},{"key":"2203_CR40","doi-asserted-by":"publisher","first-page":"11018","DOI":"10.1074\/jbc.M413499200","volume":"280","author":"S Marshall","year":"2005","unstructured":"Marshall S, Nadeau O, Yamasaki K. Glucosamine-induced activation of glycogen biosynthesis in isolated adipocytes: evidence for a rapid allosteric control mechanism within the hexosamine biosynthesis pathway. J Biol Chem. 2005;280:11018\u201324.","journal-title":"J Biol Chem"},{"key":"2203_CR41","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1016\/S0969-2126(01)00270-2","volume":"3","author":"G Oliva","year":"1995","unstructured":"Oliva G, Fontes MR, Garratt RC, Altamirano MM, Calcagno ML, Horjales E. Structure and catalytic mechanism of glucosamine 6-phosphate deaminase from Escherichia coli at 2.1 \u00c5 resolution. Structure. 1995;3:1323\u201332.","journal-title":"Structure"},{"key":"2203_CR42","doi-asserted-by":"publisher","first-page":"13147","DOI":"10.1074\/jbc.271.22.13147","volume":"271","author":"T Szumilo","year":"1996","unstructured":"Szumilo T, Zeng Y, Pastuszak I, Drake R, Szumilo H, Elbein AD. Purification to homogeneity and properties of UDP-GlcNAc (GalNAc) pyrophosphorylase. J Biol Chem. 1996;271:13147\u201354.","journal-title":"J Biol Chem"},{"key":"2203_CR43","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/0006-3002(61)91068-X","volume":"50","author":"T Pattabiraman","year":"1961","unstructured":"Pattabiraman T, Bachhawat B. Purification of uridine diphosphoacetylglucosamine pyrophosphorylase from sheep brain. Biochim Biophys Acta. 1961;50:129\u201334.","journal-title":"Biochim Biophys Acta"},{"key":"2203_CR44","first-page":"2275","volume":"40","author":"K Yamamoto","year":"1976","unstructured":"Yamamoto K, Kawai H, Moriguchi M, Tochikura T. Purification and characterization of yeast UDP-N-acetylglucosamine pyrophosphorylase. Agric Biol Chem. 1976;40:2275\u201381.","journal-title":"Agric Biol Chem"},{"key":"2203_CR45","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/S1074-5521(02)00093-5","volume":"9","author":"KA Winans","year":"2002","unstructured":"Winans KA, Bertozzi CR. An inhibitor of the human UDP-GlcNAc 4-epimerase identified from a uridine-based library: a strategy to inhibit O-linked glycosylation. Chem Biol. 2002;9:113\u201329.","journal-title":"Chem Biol"},{"key":"2203_CR46","doi-asserted-by":"publisher","first-page":"2468","DOI":"10.1074\/mcp.M112.027151","volume":"12","author":"K Nakajima","year":"2013","unstructured":"Nakajima K, Ito E, Ohtsubo K, Shirato K, Takamiya R, Kitazume S, et al. Mass isotopomer analysis of metabolically labeled nucleotide sugars and N-and O-glycans for tracing nucleotide sugar metabolisms. Mol Cell Proteom. 2013;12:2468\u201380.","journal-title":"Mol Cell Proteom"},{"key":"2203_CR47","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1016\/j.bbrc.2004.08.023","volume":"322","author":"K-C Sohn","year":"2004","unstructured":"Sohn K-C, Lee K-Y, Park JE, Do S-I. OGT functions as a catalytic chaperone under heat stress response: a unique defense role of OGT in hyperthermia. Biochem Biophys Res Commun. 2004;322:1045\u201351.","journal-title":"Biochem Biophys Res Commun"},{"key":"2203_CR48","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/S0003-9861(03)00234-0","volume":"415","author":"Y Gao","year":"2003","unstructured":"Gao Y, Miyazaki J-I, Hart GW. The transcription factor PDX-1 is post-translationally modified by O-linked N-acetylglucosamine and this modification is correlated with its DNA binding activity and insulin secretion in min6 \u03b2-cells. Arch Biochem Biophys. 2003;415:155\u201363.","journal-title":"Arch Biochem Biophys"},{"key":"2203_CR49","doi-asserted-by":"publisher","first-page":"2550","DOI":"10.1128\/MCB.17.5.2550","volume":"17","author":"I Han","year":"1997","unstructured":"Han I, Kudlow JE. Reduced O glycosylation of Sp1 is associated with increased proteasome susceptibility. Mol Cell Biol. 1997;17:2550\u20138.","journal-title":"Mol Cell Biol"},{"key":"2203_CR50","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.2337\/diabetes.51.4.1146","volume":"51","author":"LR James","year":"2002","unstructured":"James LR, Tang D, Ingram A, Ly H, Thai K, Cai L, et al. Flux through the hexosamine pathway is a determinant of nuclear factor \u03baB\u2013dependent promoter activation. Diabetes. 2002;51:1146\u201356.","journal-title":"Diabetes"},{"key":"2203_CR51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12915-019-0671-3","volume":"17","author":"NM Akella","year":"2019","unstructured":"Akella NM, Ciraku L, Reginato MJ. Fueling the fire: emerging role of the hexosamine biosynthetic pathway in cancer. BMC Biol. 2019;17:1\u201314.","journal-title":"BMC Biol"},{"key":"2203_CR52","doi-asserted-by":"publisher","first-page":"12917","DOI":"10.1074\/jbc.M116.729236","volume":"291","author":"MC Lucena","year":"2016","unstructured":"Lucena MC, Carvalho-Cruz P, Donadio JL, Oliveira IA, de Queiroz RM, Marinho-Carvalho MM, et al. Epithelial mesenchymal transition induces aberrant glycosylation through hexosamine biosynthetic pathway activation. J Biol Chem. 2016;291:12917\u201329.","journal-title":"J Biol Chem"},{"key":"2203_CR53","doi-asserted-by":"publisher","first-page":"2018","DOI":"10.1074\/jbc.RA119.010565","volume":"295","author":"AK Olson","year":"2020","unstructured":"Olson AK, Bouchard B, Zhu WZ, Chatham JC, Des Rosiers C. First characterization of glucose flux through the hexosamine biosynthesis pathway (HBP) in ex vivo mouse heart. J Biol Chem. 2020;295:2018\u201333.","journal-title":"J Biol Chem"},{"key":"2203_CR54","doi-asserted-by":"crossref","unstructured":"McClain DA, Lubas WA, Cooksey RC, Hazel M, Parker GJ, Love DC et al. Altered glycan-dependent signaling induces insulin resistance and hyperleptinemia. Proceedings of the National Academy of Sciences. 2002; 99:10695\u201310699.","DOI":"10.1073\/pnas.152346899"},{"key":"2203_CR55","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3390\/jcm12010005","volume":"12","author":"T Szponder","year":"2022","unstructured":"Szponder T, Latalski M, Danielewicz A, Kra\u0107 K, Kozera A, Drzewiecka B, et al. Osteoarthritis: pathogenesis, animal models, and new regenerative therapies. J Clin Med. 2022;12:5.","journal-title":"J Clin Med"},{"key":"2203_CR56","first-page":"929","volume":"34","author":"D Yu","year":"2016","unstructured":"Yu D, Xu J, Liu F, Wang X, Mao Y, Zhu Z. Subchondral bone changes and the impacts on joint pain and articular cartilage degeneration in osteoarthritis. Clin Exp Rheumatol. 2016;34:929\u201334.","journal-title":"Clin Exp Rheumatol"},{"key":"2203_CR57","first-page":"412","volume":"86","author":"C Allaeys","year":"2020","unstructured":"Allaeys C, Arnout N, Van Onsem S, Govaers K, Victor J. Conservative treatment of knee osteoarthritis. Acta Orthop Belg. 2020;86:412\u201321.","journal-title":"Acta Orthop Belg"},{"key":"2203_CR58","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1093\/oxfordjournals.aje.a117469","volume":"141","author":"WE Smalley","year":"1995","unstructured":"Smalley WE, Ray WA, Daugherty JR, Griffin MR. Nonsteroidal anti-inflammatory drugs and the incidence of hospitalizations for peptic ulcer disease in elderly persons. Am J Epidemiol. 1995;141:539\u201345.","journal-title":"Am J Epidemiol"},{"key":"2203_CR59","doi-asserted-by":"publisher","first-page":"385","DOI":"10.5001\/omj.2011.101","volume":"26","author":"A Al-Saeed","year":"2011","unstructured":"Al-Saeed A. Gastrointestinal and cardiovascular risk of nonsteroidal anti-inflammatory drugs. Oman Med J. 2011;26:385.","journal-title":"Oman Med J"},{"key":"2203_CR60","first-page":"1","volume":"3","author":"Rodr\u00edguezLA Garc\u00eda","year":"2005","unstructured":"Garc\u00eda Rodr\u00edguezLA, Gonz\u00e1lez-P\u00e9rez A. Long-term use of non-steroidal anti-inflammatory drugs and the risk of myocardial infarction in the general population. BMC Med. 2005;3:1\u20136.","journal-title":"BMC Med"},{"key":"2203_CR61","doi-asserted-by":"publisher","first-page":"S481","DOI":"10.1016\/j.joca.2019.02.530","volume":"27","author":"R Yin","year":"2019","unstructured":"Yin R, Su J, Colville M, Paszek M, Reesink H. Synovial fluid microrheology to identify potential candidates for viscosupplementation. Osteoarthr Cartil. 2019;27:S481.","journal-title":"Osteoarthr Cartil"},{"key":"2203_CR62","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s10616-013-9669-9","volume":"67","author":"K Uehara","year":"2015","unstructured":"Uehara K, Hara M, Matsuo T, Namiki G, Watanabe M, Nomura Y. Hyaluronic acid secretion by synoviocytes alters under Cyclic compressive load in contracted collagen gels. Cytotechnology. 2015;67:19\u201326.","journal-title":"Cytotechnology"},{"key":"2203_CR63","doi-asserted-by":"crossref","unstructured":"Masuko K, Murata M, Yudoh K, Kato T, Nakamura H. Anti-inflammatory effects of hyaluronan in arthritis therapy: not just for viscosity. Int J Gen Med 2009:77\u201381.","DOI":"10.2147\/IJGM.S5495"},{"key":"2203_CR64","first-page":"896","volume":"32","author":"J Cibere","year":"2005","unstructured":"Cibere J, Thorne A, Kopec JA, Singer J, Canvin J, Robinson DB, et al. Glucosamine sulfate and cartilage type II collagen degradation in patients with knee osteoarthritis: randomized discontinuation trial results employing biomarkers. J Rhuematol. 2005;32:896\u2013902.","journal-title":"J Rhuematol"},{"key":"2203_CR65","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1177\/1947603518770256","volume":"10","author":"V Rotter Sopasakis","year":"2019","unstructured":"Rotter Sopasakis V, Wickelgren R, Sukonina V, Brantsing C, Svala E, Hansson E, et al. Elevated glucose levels preserve glucose uptake, hyaluronan production, and low glutamate release following interleukin-1\u03b2 stimulation of differentiated chondrocytes. Cartilage. 2019;10:491\u2013503.","journal-title":"Cartilage"},{"key":"2203_CR66","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.joca.2014.09.005","volume":"23","author":"D Stoppoloni","year":"2015","unstructured":"Stoppoloni D, Politi L, Leopizzi M, Gaetani S, Guazzo R, Basciani S, et al. Effect of glucosamine and its peptidyl-derivative on the production of extracellular matrix components by human primary chondrocytes. Osteoarthr Cartil. 2015;23:103\u201313.","journal-title":"Osteoarthr Cartil"},{"key":"2203_CR67","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.joca.2006.06.008","volume":"15","author":"S Varghese","year":"2007","unstructured":"Varghese S, Theprungsirikul P, Sahani S, Hwang N, Yarema K, Elisseeff J. Glucosamine modulates chondrocyte proliferation, matrix synthesis, and gene expression. Osteoarthr Cartil. 2007;15:59\u201368.","journal-title":"Osteoarthr Cartil"},{"key":"2203_CR68","first-page":"260","volume":"3","author":"A Drovanti","year":"1980","unstructured":"Drovanti A, Bignamini A, Rovati A. Therapeutic activity of oral glucosamine sulfate in osteoarthrosis: a placebo-controlled double-blind investigation. Clin Ther. 1980;3:260\u201372.","journal-title":"Clin Ther"},{"key":"2203_CR69","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1136\/oem.51.4.275","volume":"51","author":"H Yamato","year":"1994","unstructured":"Yamato H, Hori H, Tanaka I, Higashi T, Morimoto Y, Kido M. Retention and clearance of inhaled ceramic fibres in rat lungs and development of a dissolution model. Occup Environ Med. 1994;51:275\u201380.","journal-title":"Occup Environ Med"},{"key":"2203_CR70","first-page":"157","volume":"64","author":"S Park","year":"2013","unstructured":"Park S, Hong H, Han Y, Kangwan N, Kim S, Kim E, et al. Nonsteroidal anti-inflammatory drugs (NSAID) sparing effects of glucosamine hydrochloride through N-glycosylation inhibition; strategy to rescue stomach from NSAID damage. J Physiol Pharmacol. 2013;64:157\u201365.","journal-title":"J Physiol Pharmacol"},{"key":"2203_CR71","doi-asserted-by":"publisher","first-page":"117","DOI":"10.3390\/pharmacy11040117","volume":"11","author":"NX Vo","year":"2023","unstructured":"Vo NX, Le NNH, Chu TDP, Pham HL, Dinh KXA, Che UTT, et al. Effectiveness and safety of glucosamine in osteoarthritis: a systematic review. Pharmacy. 2023;11:117.","journal-title":"Pharmacy"},{"key":"2203_CR72","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1186\/s12891-022-06046-6","volume":"23","author":"N Veronese","year":"2022","unstructured":"Veronese N, Ecarnot F, Cheleschi S, Fioravanti A, Maggi S. Possible synergic action of non-steroidal anti-inflammatory drugs and glucosamine sulfate for the treatment of knee osteoarthritis: a scoping review. BMC Musculoskelet Disord. 2022;23:1084.","journal-title":"BMC Musculoskelet Disord"},{"key":"2203_CR73","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1136\/ard.2003.011742","volume":"62","author":"K Jordan","year":"2003","unstructured":"Jordan K, Arden N, Doherty M, Bannwarth B, Bijlsma J, Dieppe P, et al. EULAR recommendations 2003: an evidence based approach to the management of knee osteoarthritis: report of a task force of the standing committee for international clinical studies including therapeutic trials (ESCISIT). Ann Rheum Dis. 2003;62:1145\u201355.","journal-title":"Ann Rheum Dis"},{"key":"2203_CR74","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.joca.2014.01.003","volume":"22","author":"TE McAlindon","year":"2014","unstructured":"McAlindon TE, Bannuru RR, Sullivan M, Arden N, Berenbaum F, Bierma-Zeinstra S, et al. OARSI guidelines for the non-surgical management of knee osteoarthritis. Osteoarthr Cartil. 2014;22:363\u201388.","journal-title":"Osteoarthr Cartil"},{"key":"2203_CR75","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.joca.2007.12.013","volume":"16","author":"W Zhang","year":"2008","unstructured":"Zhang W, Moskowitz R, Nuki G, Abramson S, Altman R, Arden N, et al. OARSI recommendations for the management of hip and knee osteoarthritis, part II: OARSI evidence-based, expert consensus guidelines. Osteoarthr Cartil. 2008;16:137\u201362.","journal-title":"Osteoarthr Cartil"},{"key":"2203_CR76","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1038\/emm.2004.31","volume":"36","author":"Y Choi","year":"2004","unstructured":"Choi Y, Lee D-J, Lim H-K, Jeong J-H, Sonn J-K, Kang S-S, et al. Interleukin-1\u03b2 stimulates matrix metalloproteinase-2 expression via a prostaglandin E2-dependent mechanism in human chondrocytes. Exp Mol Med. 2004;36:226\u201332.","journal-title":"Exp Mol Med"},{"key":"2203_CR77","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1002\/jor.22334","volume":"31","author":"AL McNulty","year":"2013","unstructured":"McNulty AL, Rothfusz NE, Leddy HA, Guilak F. Synovial fluid concentrations and relative potency of interleukin-1 alpha and beta in cartilage and meniscus degradation. J Orthop Res. 2013;31:1039\u201345.","journal-title":"J Orthop Res"},{"key":"2203_CR78","doi-asserted-by":"publisher","first-page":"S947","DOI":"10.1177\/1947603520934858","volume":"13","author":"S Zhou","year":"2021","unstructured":"Zhou S, Liu G, Si Z, Yu L, Hou L. Glycyrrhizin, an HMGB1 inhibitor, suppresses interleukin-1\u03b2-induced inflammatory responses in chondrocytes from patients with osteoarthritis. Cartilage. 2021;13:S947\u201355.","journal-title":"Cartilage"},{"key":"2203_CR79","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/S1063-4584(03)00028-1","volume":"11","author":"R Largo","year":"2003","unstructured":"Largo R, Alvarez-Soria M, D\u0131ez-Ortego I, Calvo E, Sanchez-Pernaute O, Egido J, et al. Glucosamine inhibits IL-1\u03b2-induced NF\u03baB activation in human Osteoarthritic chondrocytes. Osteoarthr Cartil. 2003;11:290\u20138.","journal-title":"Osteoarthr Cartil"},{"key":"2203_CR80","doi-asserted-by":"publisher","first-page":"8980","DOI":"10.3390\/ijms22168980","volume":"22","author":"S Cheleschi","year":"2021","unstructured":"Cheleschi S, Tenti S, Giannotti S, Veronese N, Reginster J-Y, Fioravanti A. A combination of celecoxib and glucosamine sulfate has anti-inflammatory and chondroprotective effects: results from an in vitro study on human Osteoarthritic chondrocytes. Int J Mol Sci. 2021;22:8980.","journal-title":"Int J Mol Sci"},{"key":"2203_CR81","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.bbrc.2011.01.007","volume":"405","author":"K Imagawa","year":"2011","unstructured":"Imagawa K, De Andr\u00e9s M, Hashimoto K, Pitt D, Itoi E, Goldring MB, et al. The epigenetic effect of glucosamine and a nuclear factor-kappa B (NF-kB) inhibitor on primary human chondrocytes\u2013implications for osteoarthritis. Biochem Biophys Res Commun. 2011;405:362\u20137.","journal-title":"Biochem Biophys Res Commun"},{"key":"2203_CR82","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.joca.2013.12.001","volume":"22","author":"L Tardio","year":"2014","unstructured":"Tardio L, Andr\u00e9s-Berg\u00f3s J, Zachara N, Larra\u00f1aga-Vera A, Rodriguez-Villar C, Herrero-Beaumont G, et al. O-linked N-acetylglucosamine (O-GlcNAc) protein modification is increased in the cartilage of patients with knee osteoarthritis. Osteoarthr Cartil. 2014;22:259\u201363.","journal-title":"Osteoarthr Cartil"},{"key":"2203_CR83","doi-asserted-by":"publisher","first-page":"818","DOI":"10.3390\/cells8080818","volume":"8","author":"D Tateiwa","year":"2019","unstructured":"Tateiwa D, Yoshikawa H, Kaito T. Cartilage and bone destruction in arthritis: pathogenesis and treatment strategy: a literature review. Cells. 2019;8:818.","journal-title":"Cells"},{"key":"2203_CR84","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2474-6-16","volume":"6","author":"A Escalante","year":"2005","unstructured":"Escalante A, Haas RW. Del Rinc\u00f3n I. A model of impairment and functional limitation in rheumatoid arthritis. BMC Musculoskelet Disord. 2005;6:1\u20138.","journal-title":"BMC Musculoskelet Disord"},{"key":"2203_CR85","doi-asserted-by":"publisher","first-page":"905","DOI":"10.3390\/ijms23020905","volume":"23","author":"S Jang","year":"2022","unstructured":"Jang S, Kwon E-J, Lee JJ. Rheumatoid arthritis: pathogenic roles of diverse immune cells. Int J Mol Sci. 2022;23:905.","journal-title":"Int J Mol Sci"},{"key":"2203_CR86","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.3892\/etm.2016.3045","volume":"11","author":"C Negrei","year":"2016","unstructured":"Negrei C, Bojinca V, Balanescu A, Bojinca M, Baconi D, Spandidos DA, et al. Management of rheumatoid arthritis: impact and risks of various therapeutic approaches. Experimental Therapeutic Med. 2016;11:1177\u201383.","journal-title":"Experimental Therapeutic Med"},{"key":"2203_CR87","unstructured":"Henry D, McGettigan P. Epidemiology overview of Gastrointestinal and renal toxicity of NSAIDs. Int J Clin Pract Supplement 2003:43\u20139."},{"key":"2203_CR88","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1111\/j.1365-2036.2008.03905.x","volume":"29","author":"A Rostom","year":"2009","unstructured":"Rostom A, Moayyedi P, Hunt R, Group CAoGC. Canadian consensus guidelines on long-term nonsteroidal anti\u2010inflammatory drug therapy and the need for gastroprotection: benefits versus risks. Aliment Pharmacol Ther. 2009;29:481\u201396.","journal-title":"Aliment Pharmacol Ther"},{"key":"2203_CR89","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/s00011-004-1333-6","volume":"54","author":"J Hua","year":"2005","unstructured":"Hua J, Suguro S, Hirano S, Sakamoto K, Nagaoka I. Preventive actions of a high dose of glucosamine on adjuvant arthritis in rats. Inflamm Res. 2005;54:127\u201332.","journal-title":"Inflamm Res"},{"key":"2203_CR90","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1002\/jps.23819","volume":"103","author":"A Aghazadeh-Habashi","year":"2014","unstructured":"Aghazadeh-Habashi A, Kohan MG, Asghar W, Jamali F. Glucosamine dose\/concentration-effect correlation in the rat with adjuvant arthritis. J Pharm Sci. 2014;103:760\u20137.","journal-title":"J Pharm Sci"},{"key":"2203_CR91","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/s00296-006-0197-1","volume":"27","author":"H Nakamura","year":"2007","unstructured":"Nakamura H, Masuko K, Yudoh K, Kato T, Kamada T, Kawahara T. Effects of glucosamine administration on patients with rheumatoid arthritis. Rheumatol Int. 2007;27:213\u20138.","journal-title":"Rheumatol Int"},{"key":"2203_CR92","first-page":"269","volume":"16","author":"K Mentzel","year":"1998","unstructured":"Mentzel K, Br\u00e4uer R. Matrix metalloproteinases, IL-6, and nitric oxide in rat antigen-induced arthritis. Clin Exp Rheumatol. 1998;16:269\u201376.","journal-title":"Clin Exp Rheumatol"},{"key":"2203_CR93","first-page":"3","volume":"65","author":"CO Bingham","year":"2002","unstructured":"Bingham CO. The pathogenesis of rheumatoid arthritis: pivotal cytokines involved in bone degradation and inflammation. J Rheumatol Supplement. 2002;65:3\u20139.","journal-title":"J Rheumatol Supplement"},{"key":"2203_CR94","doi-asserted-by":"publisher","first-page":"239310","DOI":"10.1155\/2012\/239310","volume":"2012","author":"MJ Fattahi","year":"2012","unstructured":"Fattahi MJ, Mirshafiey A. Prostaglandins and rheumatoid arthritis. Arthritis. 2012;2012:239310.","journal-title":"Arthritis"},{"key":"2203_CR95","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1055\/s-0036-1597577","volume":"26","author":"N Garg","year":"2017","unstructured":"Garg N, Syngle A, Krishan P. Nitric oxide: link between inflammation and endothelial dysfunction in rheumatoid arthritis. Int J Angiol. 2017;26:165\u20139.","journal-title":"Int J Angiol"},{"key":"2203_CR96","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1007\/s00011-007-7020-7","volume":"56","author":"J Hua","year":"2007","unstructured":"Hua J, Sakamoto K, Kikukawa T, Abe C, Kurosawa H, Nagaoka I. Evaluation of the suppressive actions of glucosamine on the interleukin-1\u03b2-mediated activation of synoviocytes. Inflamm Res. 2007;56:432\u20138.","journal-title":"Inflamm Res"},{"key":"2203_CR97","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1136\/ewjm.172.2.91","volume":"172","author":"JP Rindone","year":"2000","unstructured":"Rindone JP, Hiller D, Collacott E, Nordhaugen N, Arriola G. Randomized, controlled trial of glucosamine for treating osteoarthritis of the knee. West J Med. 2000;172:91.","journal-title":"West J Med"},{"key":"2203_CR98","doi-asserted-by":"crossref","unstructured":"Towheed T, Maxwell L, Anastassiades TP, Shea B, Houpt J, Welch V, et al. Glucosamine therapy for treating osteoarthritis. Cochrane database of systematic reviews; 2005.","DOI":"10.1002\/14651858.CD002946.pub2"},{"key":"2203_CR99","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1016\/j.biopha.2018.05.136","volume":"105","author":"W Dai","year":"2018","unstructured":"Dai W, Qi C, Wang S. Synergistic effect of glucosamine and vitamin E against experimental rheumatoid arthritis in neonatal rats. Biomed Pharmacother. 2018;105:835\u201340.","journal-title":"Biomed Pharmacother"},{"key":"2203_CR100","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1177\/153537020523000405","volume":"230","author":"MM Chou","year":"2005","unstructured":"Chou MM, Vergnolle N, McDougall JJ, Wallace JL, Marty S, Teskey V, et al. Effects of chondroitin and glucosamine sulfate in a dietary bar formulation on inflammation, interleukin-1\u03b2, matrix metalloprotease-9, and cartilage damage in arthritis. Experimental Biology Med. 2005;230:255\u201362.","journal-title":"Experimental Biology Med"},{"key":"2203_CR101","doi-asserted-by":"publisher","first-page":"640","DOI":"10.3892\/etm.2012.668","volume":"4","author":"Y Yamagishi","year":"2012","unstructured":"Yamagishi Y, Igarashi M, Suzuki A, Suguro S, Hirano S-I, Nagaoka I. Evaluation of the effect of methionine and glucosamine on adjuvant arthritis in rats. Experimental Therapeutic Med. 2012;4:640\u20134.","journal-title":"Experimental Therapeutic Med"},{"key":"2203_CR102","doi-asserted-by":"publisher","first-page":"34","DOI":"10.2741\/1399","volume":"9","author":"C Ospelt","year":"2004","unstructured":"Ospelt C, Neidhart M, Gay RE, Gay S. Synovial activation in rheumatoid arthritis. Front Biosci. 2004;9:34.","journal-title":"Front Biosci"},{"key":"2203_CR103","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1186\/s13287-023-03473-7","volume":"14","author":"M Babaahmadi","year":"2023","unstructured":"Babaahmadi M, Tayebi B, Gholipour NM, Kamardi MT, Heidari S, Baharvand H, et al. Rheumatoid arthritis: the old issue, the new therapeutic approach. Stem Cell Res Ther. 2023;14:268.","journal-title":"Stem Cell Res Ther"},{"key":"2203_CR104","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13075-015-0762-7","volume":"17","author":"HB Kim","year":"2015","unstructured":"Kim HB, Lee SW, Mun CH, Yoon JY, Pai J, Shin I, et al. O-linked N-acetylglucosamine glycosylation of p65 aggravated the inflammation in both fibroblast-like synoviocytes stimulated by tumor necrosis factor-\u03b1 and mice with collagen induced arthritis. Arthritis Res Therapy. 2015;17:1\u20138.","journal-title":"Arthritis Res Therapy"},{"key":"2203_CR105","doi-asserted-by":"publisher","first-page":"mjac065","DOI":"10.1093\/jmcb\/mjac065","volume":"14","author":"Y Wang","year":"2022","unstructured":"Wang Y, Fang X, Wang S, Wang B, Chu F, Tian Z, et al. The role of O-GlcNAcylation in innate immunity and inflammation. J Mol Cell Biol. 2022;14:mjac065.","journal-title":"J Mol Cell Biol"},{"key":"2203_CR106","doi-asserted-by":"publisher","first-page":"861559","DOI":"10.3389\/fimmu.2022.861559","volume":"13","author":"M Ouyang","year":"2022","unstructured":"Ouyang M, Yu C, Deng X, Zhang Y, Zhang X, Duan F. O-GlcNAcylation and its role in cancer-associated inflammation. Front Immunol. 2022;13:861559.","journal-title":"Front Immunol"},{"key":"2203_CR107","doi-asserted-by":"publisher","first-page":"S13","DOI":"10.1046\/j.1523-1755.2000.07703.x","volume":"58","author":"ED Schleicher","year":"2000","unstructured":"Schleicher ED, Weigert C. Role of the hexosamine biosynthetic pathway in diabetic nephropathy. Kidney Int. 2000;58:S13\u20138.","journal-title":"Kidney Int"},{"key":"2203_CR108","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1038\/nature06668","volume":"451","author":"X Yang","year":"2008","unstructured":"Yang X, Ongusaha PP, Miles PD, Havstad JC, Zhang F, So WV, et al. Phosphoinositide signalling links O-GlcNAc transferase to insulin resistance. Nature. 2008;451:964\u20139.","journal-title":"Nature"},{"key":"2203_CR109","doi-asserted-by":"publisher","first-page":"2501","DOI":"10.1210\/endo.138.6.5172","volume":"138","author":"A Virkam\u00e4ki","year":"1997","unstructured":"Virkam\u00e4ki A, Daniels MC, H\u00e4m\u00e4l\u00e4inen S, Utriainen T, McClain D, Yki-J\u00e4rvinen H. Activation of the hexosamine pathway by glucosamine in vivo induces insulin resistance in multiple insulin sensitive tissues. Endocrinology. 1997;138:2501\u20137.","journal-title":"Endocrinology"},{"key":"2203_CR110","doi-asserted-by":"publisher","first-page":"5313","DOI":"10.1073\/pnas.072072399","volume":"99","author":"K Vosseller","year":"2002","unstructured":"Vosseller K, Wells L, Lane MD, Hart GW. Elevated nucleocytoplasmic glycosylation by O-GlcNAc results in insulin resistance associated with defects in Akt activation in 3T3-L1 adipocytes. Proc Natl Acad Sci. 2002;99:5313\u20138.","journal-title":"Proc Natl Acad Sci"},{"key":"2203_CR111","doi-asserted-by":"publisher","first-page":"10022","DOI":"10.1074\/jbc.M207787200","volume":"278","author":"GJ Parker","year":"2003","unstructured":"Parker GJ, Lund KC, Taylor RP, McClain DA. Insulin resistance of glycogen synthase mediated byo-linked N-acetylglucosamine. J Biol Chem. 2003;278:10022\u20137.","journal-title":"J Biol Chem"},{"key":"2203_CR112","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.tem.2013.02.002","volume":"24","author":"H-B Ruan","year":"2013","unstructured":"Ruan H-B, Singh JP, Li M-D, Wu J, Yang X. Cracking the O-GlcNAc code in metabolism. Trends Endocrinol Metabolism. 2013;24:301\u20139.","journal-title":"Trends Endocrinol Metabolism"},{"key":"2203_CR113","doi-asserted-by":"publisher","first-page":"719","DOI":"10.2337\/dc19-1836","volume":"43","author":"H Ma","year":"2020","unstructured":"Ma H, Li X, Zhou T, Sun D, Liang Z, Li Y, et al. Glucosamine use, inflammation, and genetic susceptibility, and incidence of type 2 diabetes: a prospective study in UK biobank. Diabetes Care. 2020;43:719\u201325.","journal-title":"Diabetes Care"},{"key":"2203_CR114","doi-asserted-by":"publisher","first-page":"926","DOI":"10.2337\/diabetes.49.6.926","volume":"49","author":"T Monauni","year":"2000","unstructured":"Monauni T, Zenti MG, Cretti A, Daniels MC, Targher G, Caruso B, et al. Effects of glucosamine infusion on insulin secretion and insulin action in humans. Diabetes. 2000;49:926\u201335.","journal-title":"Diabetes"},{"key":"2203_CR115","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/j.metabol.2014.11.005","volume":"64","author":"J-S Hwang","year":"2015","unstructured":"Hwang J-S, Park J-W, Nam M-S, Cho H, Han I-O. Glucosamine enhances body weight gain and reduces insulin response in mice fed Chow diet but mitigates obesity, insulin resistance and impaired glucose tolerance in mice high-fat diet. Metabolism. 2015;64:368\u201379.","journal-title":"Metabolism"},{"key":"2203_CR116","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1007\/s00296-012-2401-9","volume":"33","author":"D Durmus","year":"2013","unstructured":"Durmus D, Alayli G, Aliyazicioglu Y, Buyukak\u0131ncak O, Canturk F. Effects of glucosamine sulfate and exercise therapy on serum leptin levels in patients with knee osteoarthritis: preliminary results of randomized controlled clinical trial. Rheumatol Int. 2013;33:593\u20139.","journal-title":"Rheumatol Int"},{"key":"2203_CR117","doi-asserted-by":"publisher","first-page":"F1172","DOI":"10.1152\/ajprenal.00545.2015","volume":"311","author":"R Gellai","year":"2016","unstructured":"Gellai R, Hodrea J, Lenart L, Hosszu A, Koszegi S, Balogh D, et al. Role of O-linked N-acetylglucosamine modification in diabetic nephropathy. Am J Physiology-Renal Physiol. 2016;311:F1172\u201381.","journal-title":"Am J Physiology-Renal Physiol"},{"key":"2203_CR118","doi-asserted-by":"publisher","first-page":"9334","DOI":"10.1038\/s41467-024-53601-x","volume":"15","author":"Y Lei","year":"2024","unstructured":"Lei Y, Liu Q, Chen B, Wu F, Li Y, Dong X, et al. Protein O-GlcNAcylation coupled to Hippo signaling drives vascular dysfunction in diabetic retinopathy. Nat Commun. 2024;15:9334.","journal-title":"Nat Commun"},{"key":"2203_CR119","doi-asserted-by":"crossref","unstructured":"McClain DA, Paterson AJ, Roos MD, Wei X, Kudlow JE. Glucose and glucosamine regulate growth factor gene expression in vascular smooth muscle cells. Proceedings of the National Academy of Sciences. 1992; 89:8150\u20138154.","DOI":"10.1073\/pnas.89.17.8150"},{"key":"2203_CR120","doi-asserted-by":"publisher","first-page":"C139","DOI":"10.1152\/ajpcell.00020.2010","volume":"299","author":"U Rajamani","year":"2010","unstructured":"Rajamani U, Essop MF. Hyperglycemia-mediated activation of the hexosamine biosynthetic pathway results in myocardial apoptosis. Am J Physiology-Cell Physiol. 2010;299:C139\u201347.","journal-title":"Am J Physiology-Cell Physiol"},{"key":"2203_CR121","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1007\/s00726-010-0699-8","volume":"40","author":"SA Marsh","year":"2011","unstructured":"Marsh SA, Dell\u2019Italia LJ, Chatham JC. Activation of the hexosamine biosynthesis pathway and protein O-GlcNAcylation modulate hypertrophic and cell signaling pathways in cardiomyocytes from diabetic mice. Amino Acids. 2011;40:819\u201328.","journal-title":"Amino Acids"},{"key":"2203_CR122","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.1161\/ATVBAHA.119.312192","volume":"39","author":"Y Chen","year":"2019","unstructured":"Chen Y, Zhao X, Wu H. Metabolic stress and cardiovascular disease in diabetes mellitus: the role of protein O-GlcNAc modification. Arterioscler Thromb Vasc Biol. 2019;39:1911\u201324.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2203_CR123","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1016\/j.preteyeres.2008.09.002","volume":"27","author":"B Wirostko","year":"2008","unstructured":"Wirostko B, Wong TY, Sim\u00f3 R. Vascular endothelial growth factor and diabetic complications. Prog Retin Eye Res. 2008;27:608\u201321.","journal-title":"Prog Retin Eye Res"},{"key":"2203_CR124","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.1161\/CIRCULATIONAHA.118.036344","volume":"139","author":"KJ Bubb","year":"2019","unstructured":"Bubb KJ, Aubdool AA, Moyes AJ, Lewis S, Drayton JP, Tang O, et al. Endothelial C-type natriuretic peptide is a critical regulator of angiogenesis and vascular remodeling. Circulation. 2019;139:1612\u201328.","journal-title":"Circulation"},{"key":"2203_CR125","doi-asserted-by":"crossref","unstructured":"Yang WH, Park SY, Nam HW, Kim DH, Kang JG, Kang ES et al. NF\u03baB activation is associated with its O-GlcNAcylation state under hyperglycemic conditions. Proceedings of the National Academy of Sciences. 2008; 105:17345\u201317350.","DOI":"10.1073\/pnas.0806198105"},{"key":"2203_CR126","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1084\/jem.20161105","volume":"214","author":"X Li","year":"2017","unstructured":"Li X, Zhang Z, Li L, Gong W, Lazenby AJ, Swanson BJ, et al. Myeloid-derived Cullin 3 promotes STAT3 phosphorylation by inhibiting OGT expression and protects against intestinal inflammation. J Exp Med. 2017;214:1093\u2013109.","journal-title":"J Exp Med"},{"key":"2203_CR127","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1111\/obr.12646","volume":"19","author":"F Haczeyni","year":"2018","unstructured":"Haczeyni F, Bell-Anderson KS, Farrell G. Causes and mechanisms of adipocyte enlargement and adipose expansion. Obes Rev. 2018;19:406\u201320.","journal-title":"Obes Rev"},{"key":"2203_CR128","doi-asserted-by":"publisher","first-page":"5487","DOI":"10.1074\/jbc.RA118.005183","volume":"294","author":"Y Gao","year":"2019","unstructured":"Gao Y, Liu J, Bai Z, Sink S, Zhao C, Lorenzo FR, et al. Iron down-regulates leptin by suppressing protein O-GlcNAc modification in adipocytes, resulting in decreased levels of O-glycosylated CREB. J Biol Chem. 2019;294:5487\u201395.","journal-title":"J Biol Chem"},{"key":"2203_CR129","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.mce.2009.09.022","volume":"318","author":"CF Teo","year":"2010","unstructured":"Teo CF, Wollaston-Hayden EE, Wells L. Hexosamine flux, the O-GlcNAc modification, and the development of insulin resistance in adipocytes. Mol Cell Endocrinol. 2010;318:44\u201353.","journal-title":"Mol Cell Endocrinol"},{"key":"2203_CR130","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1038\/31474","volume":"393","author":"J Wang","year":"1998","unstructured":"Wang J, Liu R, Hawkins M, Barzilai N, Rossetti L. A nutrient-sensing pathway regulates leptin gene expression in muscle and fat. Nature. 1998;393:684\u20138.","journal-title":"Nature"},{"key":"2203_CR131","first-page":"3551","volume":"85","author":"RV Considine","year":"2000","unstructured":"Considine RV, Cooksey RC, Williams LB, Fawcett RL, Zhang P, Ambrosius WT, et al. Hexosamines regulate leptin production in human subcutaneous adipocytes. J Clin Endocrinol Metabolism. 2000;85:3551\u20136.","journal-title":"J Clin Endocrinol Metabolism"},{"key":"2203_CR132","first-page":"158764","volume":"1865","author":"J Park","year":"2020","unstructured":"Park J, Lee Y, Jung E-H, Kim S-M, Cho H, Han I-O. Glucosamine regulates hepatic lipid accumulation by sensing glucose levels or feeding States of normal and excess. Biochim Et Biophys Acta (BBA)-Molecular Cell Biology Lipids. 2020;1865:158764.","journal-title":"Biochim Et Biophys Acta (BBA)-Molecular Cell Biology Lipids"},{"key":"2203_CR133","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/s41467-019-13914-8","volume":"11","author":"Y Yang","year":"2020","unstructured":"Yang Y, Fu M, Li M, Zhang K, Zhang B, Wang S, et al. O-GlcNAc transferase inhibits visceral fat lipolysis and promotes diet-induced obesity. Nat Comm. 2020;11:181.","journal-title":"Nat Comm"},{"key":"2203_CR134","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s12929-022-00851-w","volume":"29","author":"T Issad","year":"2022","unstructured":"Issad T, Al-Mukh H, Bouaboud A, Pagesy P. Protein O-GlcNAcylation and the regulation of energy homeostasis: lessons from knock-out mouse models. J Biomed Sci. 2022;29:64.","journal-title":"J Biomed Sci"},{"key":"2203_CR135","doi-asserted-by":"publisher","first-page":"5103","DOI":"10.1038\/s41467-018-07461-x","volume":"9","author":"M-D Li","year":"2018","unstructured":"Li M-D, Vera NB, Yang Y, Zhang B, Ni W, Ziso-Qejvanaj E, et al. Adipocyte OGT governs diet-induced hyperphagia and obesity. Nat Commun. 2018;9:5103.","journal-title":"Nat Commun"},{"key":"2203_CR136","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1002\/mnfr.200600226","volume":"51","author":"MM Rafi","year":"2007","unstructured":"Rafi MM, Yadav PN, Rossi AO. Glucosamine inhibits LPS-induced COX\u20102 and iNOS expression in mouse macrophage cells (RAW 264.7) by Inhibition of p38\u2010MAP kinase and transcription factor NF\u2010\u03baB. Mol Nutr Food Res. 2007;51:587\u201393.","journal-title":"Mol Nutr Food Res"},{"key":"2203_CR137","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1006\/bbrc.2000.3912","volume":"279","author":"CJ Meininger","year":"2000","unstructured":"Meininger CJ, Kelly KA, Li H, Haynes TE, Wu G. Glucosamine inhibits inducible nitric oxide synthesis. Biochem Biophys Res Commun. 2000;279:234\u20139.","journal-title":"Biochem Biophys Res Commun"},{"key":"2203_CR138","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.niox.2013.02.082","volume":"31","author":"S-Y Hwang","year":"2013","unstructured":"Hwang S-Y, Hwang J-S, Kim S-Y, Han I-O. Glucosamine inhibits lipopolysaccharide-stimulated inducible nitric oxide synthase induction by inhibiting expression of NF-kappaB\/Rel proteins at the mRNA and protein levels. Nitric Oxide. 2013;31:1\u20138.","journal-title":"Nitric Oxide"},{"key":"2203_CR139","doi-asserted-by":"publisher","first-page":"e0165158","DOI":"10.1371\/journal.pone.0165158","volume":"11","author":"A Someya","year":"2016","unstructured":"Someya A, Ikegami T, Sakamoto K, Nagaoka I. Glucosamine downregulates the IL-1\u03b2-induced expression of Proinflammatory cytokine genes in human synovial MH7A cells by O-GlcNAc modification-dependent and-independent mechanisms. PLoS ONE. 2016;11:e0165158.","journal-title":"PLoS ONE"},{"key":"2203_CR140","doi-asserted-by":"crossref","unstructured":"Chen C-L, Liang C-M, Chen Y-H, Tai M-C, Lu D-W, Chen J-T. Glucosamine Modulates TNF-\u03b1\u2013Induced ICAM-1 Expression and Function Through O-Linked and N-Linked Glycosylation in Human Retinal Pigment Epithelial Cells. Investigative ophthalmology & visual science. 2012; 53:2281\u20132291.","DOI":"10.1167\/iovs.11-9291"},{"key":"2203_CR141","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1111\/jgh.12485","volume":"29","author":"YK Bak","year":"2014","unstructured":"Bak YK, Lampe JW, Sung MK. Effects of dietary supplementation of glucosamine sulfate on intestinal inflammation in a mouse model of experimental colitis. J Gastroenterol Hepatol. 2014;29:957\u201363.","journal-title":"J Gastroenterol Hepatol"},{"key":"2203_CR142","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1016\/j.joca.2010.05.012","volume":"18","author":"Z-H Wen","year":"2010","unstructured":"Wen Z-H, Tang C-C, Chang Y-C, Huang S-Y, Hsieh S-P, Lee C-H, et al. Glucosamine sulfate reduces experimental osteoarthritis and nociception in rats: association with changes of mitogen-activated protein kinase in chondrocytes. Osteoarthr Cartil. 2010;18:1192\u2013202.","journal-title":"Osteoarthr Cartil"},{"key":"2203_CR143","doi-asserted-by":"publisher","first-page":"1724","DOI":"10.1074\/jbc.M116.737940","volume":"292","author":"J-S Hwang","year":"2017","unstructured":"Hwang J-S, Kwon M-Y, Kim K-H, Lee Y, Lyoo IK, Kim JE, et al. Lipopolysaccharide (LPS)-stimulated iNOS induction is increased by glucosamine under normal glucose conditions but is inhibited by glucosamine under high glucose conditions in macrophage cells. J Biol Chem. 2017;292:1724\u201336.","journal-title":"J Biol Chem"},{"key":"2203_CR144","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.3389\/fphys.2019.01614","volume":"10","author":"JF Silva","year":"2020","unstructured":"Silva JF, Olivon VC, Mestriner FLA, Zanotto CZ, Ferreira RG, Ferreira NS, et al. Acute increase in O-GlcNAc improves survival in mice with LPS-induced systemic inflammatory response syndrome. Front Physiol. 2020;10:1614.","journal-title":"Front Physiol"},{"key":"2203_CR145","doi-asserted-by":"publisher","first-page":"5155","DOI":"10.4049\/jimmunol.166.8.5155","volume":"166","author":"AR S","year":"2001","unstructured":"AR S. N-acetylglucosamine prevents IL-1 beta-mediated activation of human chondrocytes. J Immunol. 2001;166:5155\u201360.","journal-title":"J Immunol"},{"key":"2203_CR146","doi-asserted-by":"publisher","first-page":"5603","DOI":"10.1038\/s41598-019-42130-z","volume":"9","author":"H-W Chiu","year":"2019","unstructured":"Chiu H-W, Li L-H, Hsieh C-Y, Rao YK, Chen F-H, Chen A, et al. Glucosamine inhibits IL-1\u03b2 expression by preserving mitochondrial integrity and disrupting assembly of the NLRP3 inflammasome. Sci Rep. 2019;9:5603.","journal-title":"Sci Rep"},{"key":"2203_CR147","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1165\/rcmb.2013-0022OC","volume":"49","author":"K-H Chuang","year":"2013","unstructured":"Chuang K-H, Peng Y-C, Chien H-Y, Lu M-L, Du H-I, Wu Y-L. Attenuation of LPS-induced lung inflammation by glucosamine in rats. Am J Respir Cell Mol Biol. 2013;49:1110\u20139.","journal-title":"Am J Respir Cell Mol Biol"},{"key":"2203_CR148","doi-asserted-by":"publisher","first-page":"7202","DOI":"10.4049\/jimmunol.175.11.7202","volume":"175","author":"G-X Zhang","year":"2005","unstructured":"Zhang G-X, Yu S, Gran B, Rostami A. Glucosamine abrogates the acute phase of experimental autoimmune encephalomyelitis by induction of Th2 response. J Immunol. 2005;175:7202\u20138.","journal-title":"J Immunol"},{"key":"2203_CR149","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1074\/jbc.RA118.004638","volume":"294","author":"J-S Hwang","year":"2019","unstructured":"Hwang J-S, Kim K-H, Park J, Kim S-M, Cho H, Lee Y, et al. Glucosamine improves survival in a mouse model of sepsis and attenuates sepsis-induced lung injury and inflammation. J Biol Chem. 2019;294:608\u201322.","journal-title":"J Biol Chem"},{"key":"2203_CR150","doi-asserted-by":"publisher","first-page":"e819","DOI":"10.1002\/ctm2.819","volume":"12","author":"M Wysoczynski","year":"2022","unstructured":"Wysoczynski M, Stephan J, Uchida S. Glucosamine regulates macrophage function in heart failure. Clin Translational Med. 2022;12:e819.","journal-title":"Clin Translational Med"},{"key":"2203_CR151","doi-asserted-by":"publisher","first-page":"2499","DOI":"10.4049\/jimmunol.2000345","volume":"205","author":"H Al-Mukh","year":"2020","unstructured":"Al-Mukh H, Baudoin L, Bouaboud A, Sanchez-Salgado J-L, Maraqa N, Khair M, et al. Lipopolysaccharide induces GFAT2 expression to promote O-linked \u03b2-N-acetylglucosaminylation and attenuate inflammation in macrophages. J Immunol. 2020;205:2499\u2013510.","journal-title":"J Immunol"},{"key":"2203_CR152","doi-asserted-by":"publisher","first-page":"16616","DOI":"10.1073\/pnas.1916121117","volume":"117","author":"Y Yang","year":"2020","unstructured":"Yang Y, Li X, Luan HH, Zhang B, Zhang K, Nam JH, et al. OGT suppresses S6K1-mediated macrophage inflammation and metabolic disturbance. Proc Natl Acad Sci. 2020;117:16616\u201325.","journal-title":"Proc Natl Acad Sci"},{"key":"2203_CR153","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/j.immuni.2019.01.007","volume":"50","author":"X Li","year":"2019","unstructured":"Li X, Gong W, Wang H, Li T, Attri KS, Lewis RE, et al. O-GlcNAc transferase suppresses inflammation and necroptosis by targeting receptor-interacting serine\/threonine-protein kinase 3. Immunity. 2019;50:576\u201390. e6.","journal-title":"Immunity"},{"key":"2203_CR154","doi-asserted-by":"publisher","first-page":"105411","DOI":"10.1016\/j.jbc.2023.105411","volume":"299","author":"MR Pratt","year":"2023","unstructured":"Pratt MR, Vocadlo DJ. Understanding and exploiting the roles of O-GlcNAc in neurodegenerative diseases. J Biol Chem. 2023;299:105411.","journal-title":"J Biol Chem"},{"key":"2203_CR155","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1212\/WNL.0000000000000328","volume":"82","author":"EE Benarroch","year":"2014","unstructured":"Benarroch EE. Brain glucose transporters: implications for neurologic disease. Neurology. 2014;82:1374\u20139.","journal-title":"Neurology"},{"key":"2203_CR156","doi-asserted-by":"publisher","first-page":"530219","DOI":"10.3389\/fnins.2020.530219","volume":"14","author":"X Yan","year":"2020","unstructured":"Yan X, Hu Y, Wang B, Wang S, Zhang X. Metabolic dysregulation contributes to the progression of alzheimer\u2019s disease. Front NeuroSci. 2020;14:530219.","journal-title":"Front NeuroSci"},{"key":"2203_CR157","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1177\/0271678X221135061","volume":"43","author":"TS McDonald","year":"2023","unstructured":"McDonald TS, Lerskiatiphanich T, Woodruff TM, McCombe PA, Lee JD. Potential mechanisms to modify impaired glucose metabolism in neurodegenerative disorders. J Cereb Blood Flow Metabolism. 2023;43:26\u201343.","journal-title":"J Cereb Blood Flow Metabolism"},{"key":"2203_CR158","doi-asserted-by":"publisher","first-page":"110672","DOI":"10.1016\/j.brainresbull.2023.110672","volume":"199","author":"C Dai","year":"2023","unstructured":"Dai C, Tan C, Zhao L, Liang Y, Liu G, Liu H, et al. Glucose metabolism impairment in parkinson\u2019s disease. Brain Res Bull. 2023;199:110672.","journal-title":"Brain Res Bull"},{"key":"2203_CR159","doi-asserted-by":"publisher","first-page":"1820","DOI":"10.1093\/brain\/awp099","volume":"132","author":"F Liu","year":"2009","unstructured":"Liu F, Shi J, Tanimukai H, Gu J, Gu J, Grundke-Iqbal I, et al. Reduced O-GlcNAcylation links lower brain glucose metabolism and Tau pathology in alzheimer\u2019s disease. Brain. 2009;132:1820\u201332.","journal-title":"Brain"},{"key":"2203_CR160","doi-asserted-by":"publisher","first-page":"779","DOI":"10.4103\/1673-5374.354515","volume":"18","author":"C-W Huang","year":"2023","unstructured":"Huang C-W, Rust NC, Wu H-F, Hart GW. Altered O-GlcNAcylation and mitochondrial dysfunction, a molecular link between brain glucose dysregulation and sporadic alzheimer\u2019s disease. Neural Regeneration Res. 2023;18:779\u201383.","journal-title":"Neural Regeneration Res"},{"key":"2203_CR161","doi-asserted-by":"crossref","unstructured":"Pinho TS, Correia SC, Perry G, Ambrosio AF, Moreira PI. Diminished O-GlcNAcylation in Alzheimer\u2019s disease is strongly correlated with mitochondrial anomalies. Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 2019; 1865:2048\u201359.","DOI":"10.1016\/j.bbadis.2018.10.037"},{"key":"2203_CR162","doi-asserted-by":"publisher","first-page":"237","DOI":"10.3233\/JAD-170211","volume":"61","author":"JPA Dos Santos","year":"2017","unstructured":"Dos Santos JPA, Vizuete A, Hansen F, Biasibetti R, Gon\u00e7alves C-A. Early and persistent O-GlcNAc protein modification in the streptozotocin model of alzheimer\u2019s disease. J Alzheimer\u2019s Disease. 2017;61:237\u201349.","journal-title":"J Alzheimer\u2019s Disease"},{"key":"2203_CR163","doi-asserted-by":"crossref","unstructured":"Liu F, Iqbal K, Grundke-Iqbal I, Hart GW, Gong C-X. O-GlcNAcylation regulates phosphorylation of tau: a mechanism involved in Alzheimer\u2019s disease. Proceedings of the National Academy of Sciences. 2004; 101:10804\u201310809.","DOI":"10.1073\/pnas.0400348101"},{"key":"2203_CR164","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1750-1326-9-42","volume":"9","author":"SA Yuzwa","year":"2014","unstructured":"Yuzwa SA, Shan X, Jones BA, Zhao G, Woodward ML, Li X, et al. Pharmacological Inhibition of O-GlcNAcase (OGA) prevents cognitive decline and amyloid plaque formation in bigenic tau\/APP mutant mice. Mol Neurodegeneration. 2014;9:1\u201314.","journal-title":"Mol Neurodegeneration"},{"key":"2203_CR165","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13024-017-0181-0","volume":"12","author":"NB Hastings","year":"2017","unstructured":"Hastings NB, Wang X, Song L, Butts BD, Grotz D, Hargreaves R, et al. Inhibition of O-GlcNAcase leads to elevation of O-GlcNAc Tau and reduction of Tauopathy and cerebrospinal fluid Tau in rTg4510 mice. Mol Neurodegeneration. 2017;12:1\u201316.","journal-title":"Mol Neurodegeneration"},{"key":"2203_CR166","doi-asserted-by":"publisher","first-page":"eabd3207","DOI":"10.1126\/sciadv.abd3207","volume":"7","author":"J Park","year":"2021","unstructured":"Park J, Ha H-J, Chung ES, Baek SH, Cho Y, Kim HK, et al. O-GlcNAcylation ameliorates the pathological manifestations of alzheimer\u2019s disease by inhibiting necroptosis. Sci Adv. 2021;7:eabd3207.","journal-title":"Sci Adv"},{"key":"2203_CR167","doi-asserted-by":"publisher","first-page":"135","DOI":"10.31083\/j.jin2205135","volume":"22","author":"N Rostgaard","year":"2023","unstructured":"Rostgaard N, Jul PH, Garmer M, Volbracht C. Increasing O-GlcNAcylation attenuates Tau hyperphosphorylation and behavioral impairment in rTg4510 Tauopathy mice. J Integr Neurosci. 2023;22:135.","journal-title":"J Integr Neurosci"},{"key":"2203_CR168","doi-asserted-by":"publisher","first-page":"8738","DOI":"10.1007\/s12035-018-1017-9","volume":"55","author":"Y Lee","year":"2018","unstructured":"Lee Y, Lee S, Park J-W, Hwang J-S, Kim S-M, Lyoo IK, et al. Hypoxia-induced neuroinflammation and learning\u2013memory impairments in adult zebrafish are suppressed by glucosamine. Mol Neurobiol. 2018;55:8738\u201353.","journal-title":"Mol Neurobiol"},{"key":"2203_CR169","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1186\/s12974-024-03179-4","volume":"21","author":"DY Kim","year":"2024","unstructured":"Kim DY, Kim S-M, Han I-O. Chronic rapid eye movement sleep deprivation aggravates the pathogenesis of alzheimer\u2019s disease by decreasing brain O-GlcNAc cycling in mice. J Neuroinflamm. 2024;21:180.","journal-title":"J Neuroinflamm"},{"key":"2203_CR170","doi-asserted-by":"publisher","first-page":"273","DOI":"10.3233\/JAD-201450","volume":"81","author":"D Pan","year":"2021","unstructured":"Pan D, Gu J-H, Zhang J, Hu Y, Liu F, Iqbal K, et al. Thiamme2-G, a novel O-GlcNAcase inhibitor, reduces Tau hyperphosphorylation and rescues cognitive impairment in mice. J Alzheimer\u2019s Disease. 2021;81:273\u201386.","journal-title":"J Alzheimer\u2019s Disease"},{"key":"2203_CR171","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1186\/s12974-023-02824-8","volume":"20","author":"X Dong","year":"2023","unstructured":"Dong X, Shu L, Zhang J, Yang X, Cheng X, Zhao X, et al. Ogt-mediated O-GlcNAcylation inhibits astrocytes activation through modulating NF-\u03baB signaling pathway. J Neuroinflamm. 2023;20:146.","journal-title":"J Neuroinflamm"},{"key":"2203_CR172","doi-asserted-by":"publisher","first-page":"958","DOI":"10.3390\/brainsci10120958","volume":"10","author":"MA Rahman","year":"2020","unstructured":"Rahman MA, Cho Y, Hwang H, Rhim H. Pharmacological Inhibition of O-GlcNAc transferase promotes mTOR-dependent autophagy in rat cortical neurons. Brain Sci. 2020;10:958.","journal-title":"Brain Sci"},{"key":"2203_CR173","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1038\/s41398-023-02446-x","volume":"13","author":"P Pradeep","year":"2023","unstructured":"Pradeep P, Kang H, Lee B. Glycosylation and behavioral symptoms in neurological disorders. Translational Psychiatry. 2023;13:154.","journal-title":"Translational Psychiatry"},{"key":"2203_CR174","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1038\/nchem.2361","volume":"7","author":"NP Marotta","year":"2015","unstructured":"Marotta NP, Lin YH, Lewis YE, Ambroso MR, Zaro BW, Roth MT, et al. O-GlcNAc modification blocks the aggregation and toxicity of the protein \u03b1-synuclein associated with parkinson\u2019s disease. Nat Chem. 2015;7:913\u201320.","journal-title":"Nat Chem"},{"key":"2203_CR175","doi-asserted-by":"publisher","first-page":"016002","DOI":"10.1088\/1478-3975\/abb6dc","volume":"18","author":"K Wu","year":"2020","unstructured":"Wu K, Li D, Xiu P, Ji B, Diao J. O-GlcNAcylation inhibits the oligomerization of alpha-synuclein by declining intermolecular hydrogen bonds through a steric effect. Phys Biol. 2020;18:016002.","journal-title":"Phys Biol"},{"key":"2203_CR176","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1111\/febs.15349","volume":"288","author":"O Tavassoly","year":"2021","unstructured":"Tavassoly O, Yue J, Vocadlo DJ. Pharmacological Inhibition and knockdown of O-GlcNAcase reduces cellular internalization of \u03b1\u2010synuclein preformed fibrils. FEBS J. 2021;288:452\u201370.","journal-title":"FEBS J"},{"key":"2203_CR177","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13041-017-0311-1","volume":"10","author":"WY Wani","year":"2017","unstructured":"Wani WY, Ouyang X, Benavides GA, Redmann M, Cofield SS, Shacka JJ, et al. O-GlcNAc regulation of autophagy and \u03b1-synuclein homeostasis; implications for parkinson\u2019s disease. Mol Brain. 2017;10:1\u201314.","journal-title":"Mol Brain"},{"key":"2203_CR178","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1038\/s41419-024-06670-1","volume":"15","author":"DY Kim","year":"2024","unstructured":"Kim DY, Kim S-M, Cho E-J, Kwak H-B, Han I-O. Protective effect of increased O-GlcNAc cycling against 6-OHDA induced parkinson\u2019s disease pathology. Cell Death Dis. 2024;15:287.","journal-title":"Cell Death Dis"},{"key":"2203_CR179","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1002\/glia.21058","volume":"58","author":"SY Hwang","year":"2010","unstructured":"Hwang SY, Shin JH, Hwang JS, Kim SY, Shin JA, Oh ES, et al. Glucosamine exerts a neuroprotective effect via suppression of inflammation in rat brain ischemia\/reperfusion injury. Glia. 2010;58:1881\u201392.","journal-title":"Glia"},{"key":"2203_CR180","doi-asserted-by":"publisher","first-page":"10686","DOI":"10.1038\/s41598-017-10635-0","volume":"7","author":"J-h Gu","year":"2017","unstructured":"Gu J-h, Shi J, Dai C-l, Ge J-b, Zhao Y, Chen Y, et al. O-GlcNAcylation reduces Ischemia-Reperfusion\u2013Induced brain injury. Sci Rep. 2017;7:10686.","journal-title":"Sci Rep"},{"key":"2203_CR181","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1042\/CS20150777","volume":"130","author":"VV Lima","year":"2016","unstructured":"Lima VV, Giachini FR, Matsumoto T, Li W, Bressan AF, Chawla D, et al. High-fat diet increases O-GlcNAc levels in cerebral arteries: a link to vascular dysfunction associated with hyperlipidaemia\/obesity? Clin Sci. 2016;130:871\u201380.","journal-title":"Clin Sci"},{"key":"2203_CR182","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1126\/science.1160809","volume":"324","author":"MG Vander Heiden","year":"2009","unstructured":"Vander Heiden MG, Cantley LC, Thompson CB. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science. 2009;324:1029\u201333.","journal-title":"Science"},{"key":"2203_CR183","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1752-0509-4-58","volume":"4","author":"A Vazquez","year":"2010","unstructured":"Vazquez A, Liu J, Zhou Y, Oltvai ZN. Catabolic efficiency of aerobic glycolysis: the Warburg effect revisited. BMC Syst Biol. 2010;4:1\u20139.","journal-title":"BMC Syst Biol"},{"key":"2203_CR184","doi-asserted-by":"publisher","first-page":"897","DOI":"10.3892\/mmr.2014.2269","volume":"10","author":"Y Gu","year":"2014","unstructured":"Gu Y, Gao J, Han C, Zhang X, Liu H, Ma L, et al. O-GlcNAcylation is increased in prostate cancer tissues and enhances malignancy of prostate cancer cells. Mol Med Rep. 2014;10:897\u2013904.","journal-title":"Mol Med Rep"},{"key":"2203_CR185","doi-asserted-by":"publisher","first-page":"216258","DOI":"10.1016\/j.canlet.2023.216258","volume":"566","author":"X-F He","year":"2023","unstructured":"He X-F, Hu X, Wen G-J, Wang Z, Lin W-J. O-GlcNAcylation in cancer development and immunotherapy. Cancer Lett. 2023;566:216258.","journal-title":"Cancer Lett"},{"key":"2203_CR186","doi-asserted-by":"publisher","first-page":"11070","DOI":"10.1074\/jbc.M111.302547","volume":"287","author":"TP Lynch","year":"2012","unstructured":"Lynch TP, Ferrer CM, Jackson SR, Shahriari KS, Vosseller K, Reginato MJ. Critical role of O-Linked \u03b2-N-acetylglucosamine transferase in prostate cancer invasion, angiogenesis, and metastasis. J Biol Chem. 2012;287:11070\u201381.","journal-title":"J Biol Chem"},{"key":"2203_CR187","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1016\/j.bbagen.2019.04.002","volume":"1863","author":"V Makwana","year":"2019","unstructured":"Makwana V, Ryan P, Patel B, Dukie S-A, Rudrawar S. Essential role of O-GlcNAcylation in stabilization of oncogenic factors. Biochim Et Biophys Acta (BBA)-General Subj. 2019;1863:1302\u201317.","journal-title":"Biochim Et Biophys Acta (BBA)-General Subj"},{"key":"2203_CR188","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s10863-018-9751-2","volume":"50","author":"JA Hanover","year":"2018","unstructured":"Hanover JA, Chen W, Bond MR. O-GlcNAc in cancer: an Oncometabolism-fueled vicious cycle. J Bioenerg Biomembr. 2018;50:155\u201373.","journal-title":"J Bioenerg Biomembr"},{"key":"2203_CR189","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1186\/s10020-022-00544-y","volume":"28","author":"Q Lu","year":"2022","unstructured":"Lu Q, Zhang X, Liang T, Bai X. O-GlcNAcylation: an important post-translational modification and a potential therapeutic target for cancer therapy. Mol Med. 2022;28:115.","journal-title":"Mol Med"},{"key":"2203_CR190","doi-asserted-by":"publisher","first-page":"e56458","DOI":"10.15252\/embr.202256458","volume":"24","author":"Y Liu","year":"2023","unstructured":"Liu Y, Yu K, Zhang K, Niu M, Chen Q, Liu Y, et al. O-GlcNAcylation promotes topoisomerase II\u03b1 catalytic activity in breast cancer chemoresistance. EMBO Rep. 2023;24:e56458.","journal-title":"EMBO Rep"},{"key":"2203_CR191","doi-asserted-by":"publisher","first-page":"34457","DOI":"10.1074\/jbc.R114.577718","volume":"289","author":"Z Ma","year":"2014","unstructured":"Ma Z, Vosseller K. Cancer metabolism and elevated O-GlcNAc in oncogenic signaling. J Biol Chem. 2014;289:34457\u201365.","journal-title":"J Biol Chem"},{"key":"2203_CR192","doi-asserted-by":"publisher","first-page":"15121","DOI":"10.1074\/jbc.M113.470047","volume":"288","author":"Z Ma","year":"2013","unstructured":"Ma Z, Vocadlo DJ, Vosseller K. Hyper-O-GlcNAcylation is anti-apoptotic and maintains constitutive NF-\u03baB activity in pancreatic cancer cells. J Biol Chem. 2013;288:15121\u201330.","journal-title":"J Biol Chem"},{"key":"2203_CR193","doi-asserted-by":"publisher","first-page":"2831","DOI":"10.1038\/onc.2010.41","volume":"29","author":"S Caldwell","year":"2010","unstructured":"Caldwell S, Jackson S, Shahriari K, Lynch T, Sethi G, Walker S, et al. Nutrient sensor O-GlcNAc transferase regulates breast cancer tumorigenesis through targeting of the oncogenic transcription factor FoxM1. Oncogene. 2010;29:2831\u201342.","journal-title":"Oncogene"},{"key":"2203_CR194","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1126\/science.1222278","volume":"337","author":"W Yi","year":"2012","unstructured":"Yi W, Clark PM, Mason DE, Keenan MC, Hill C, Goddard WA, et al. Phosphofructokinase 1 glycosylation regulates cell growth and metabolism. Science. 2012;337:975\u201380.","journal-title":"Science"},{"key":"2203_CR195","doi-asserted-by":"publisher","first-page":"e37427","DOI":"10.1371\/journal.pone.0037427","volume":"7","author":"S Wang","year":"2012","unstructured":"Wang S, Huang X, Sun D, Xin X, Pan Q, Peng S, et al. Extensive crosstalk between O-GlcNAcylation and phosphorylation regulates Akt signaling. PLoS ONE. 2012;7:e37427.","journal-title":"PLoS ONE"},{"key":"2203_CR196","doi-asserted-by":"publisher","first-page":"9150","DOI":"10.1074\/jbc.M116.766568","volume":"292","author":"Z Ma","year":"2017","unstructured":"Ma Z, Chalkley RJ, Vosseller K. Hyper-O-GlcNAcylation activates nuclear factor \u03ba-light-chain-enhancer of activated B cells (NF-\u03baB) signaling through interplay with phosphorylation and acetylation. J Biol Chem. 2017;292:9150\u201363.","journal-title":"J Biol Chem"},{"key":"2203_CR197","doi-asserted-by":"publisher","first-page":"3431","DOI":"10.1073\/pnas.0813210106","volume":"106","author":"K Kawauchi","year":"2009","unstructured":"Kawauchi K, Araki K, Tobiume K, Tanaka N. Loss of p53 enhances catalytic activity of IKK\u03b2 through O-linked \u03b2-N-acetyl glucosamine modification. Proc Natl Acad Sci. 2009;106:3431\u20136.","journal-title":"Proc Natl Acad Sci"},{"key":"2203_CR198","doi-asserted-by":"crossref","unstructured":"Zhang D, Qi Y, Inuzuka H, Liu J, Wei W. O-GlcNAcylation in tumorigenesis and its implications for cancer therapy. J Biol Chem 2024:107709.","DOI":"10.1016\/j.jbc.2024.107709"},{"key":"2203_CR199","first-page":"1305","volume":"12","author":"D Xu","year":"2019","unstructured":"Xu D, Wang W, Bian T, Yang W, Shao M, Yang H. Increased expression of O-GlcNAc transferase (OGT) is a biomarker for poor prognosis and allows tumorigenesis and invasion in colon cancer. Int J Clin Exp Pathol. 2019;12:1305.","journal-title":"Int J Clin Exp Pathol"},{"key":"2203_CR200","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12885-018-5033-y","volume":"18","author":"L Wang","year":"2018","unstructured":"Wang L, Chen S, Zhang Z, Zhang J, Mao S, Zheng J, et al. Suppressed OGT expression inhibits cell proliferation while inducing cell apoptosis in bladder cancer. BMC Cancer. 2018;18:1\u201312.","journal-title":"BMC Cancer"},{"key":"2203_CR201","doi-asserted-by":"publisher","first-page":"61390","DOI":"10.18632\/oncotarget.11359","volume":"7","author":"M Jiang","year":"2016","unstructured":"Jiang M, Qiu Z, Zhang S, Fan X, Cai X, Xu B, et al. Elevated O-GlcNAcylation promotes gastric cancer cells proliferation by modulating cell cycle related proteins and ERK 1\/2 signaling. Oncotarget. 2016;7:61390.","journal-title":"Oncotarget"},{"key":"2203_CR202","doi-asserted-by":"crossref","unstructured":"Jin L, Lu M, Dai G, Yao Q, Xiang H, Wang L et al. O-GlcNAcylation promotes malignant phenotypes of bladder cancer cells. Neoplasma 2020; 67.","DOI":"10.4149\/neo_2020_191006N1009"},{"key":"2203_CR203","doi-asserted-by":"publisher","first-page":"13732","DOI":"10.1073\/pnas.1704145115","volume":"114","author":"Y Wang","year":"2017","unstructured":"Wang Y, Liu J, Jin X, Zhang D, Li D, Hao F, et al. O-GlcNAcylation destabilizes the active tetrameric PKM2 to promote the Warburg effect. Proc Natl Acad Sci. 2017;114:13732\u20137.","journal-title":"Proc Natl Acad Sci"},{"key":"2203_CR204","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1038\/s41467-019-13601-8","volume":"11","author":"H Nie","year":"2020","unstructured":"Nie H, Ju H, Fan J, Shi X, Cheng Y, Cang X, et al. O-GlcNAcylation of PGK1 coordinates Glycolysis and TCA cycle to promote tumor growth. Nat Commun. 2020;11:36.","journal-title":"Nat Commun"},{"key":"2203_CR205","doi-asserted-by":"publisher","first-page":"794","DOI":"10.3892\/mmr.2013.1584","volume":"8","author":"Y Ju","year":"2013","unstructured":"Ju Y, Yu A, Sun X, Wu D, Zhang H. Glucosamine, a naturally occurring amino monosaccharide, inhibits A549 and H446 cell proliferation by blocking G1\/S transition. Mol Med Rep. 2013;8:794\u20138.","journal-title":"Mol Med Rep"},{"key":"2203_CR206","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12894-017-0221-7","volume":"17","author":"L-s Wang","year":"2017","unstructured":"Wang L-s, Chen S-j, Zhang J-f, Liu M-n, Zheng J-h. Yao X-d. Anti-proliferative potential of glucosamine in renal cancer cells via inducing cell cycle arrest at G0\/G1 phase. BMC Urol. 2017;17:1\u20138.","journal-title":"BMC Urol"},{"key":"2203_CR207","doi-asserted-by":"crossref","unstructured":"Samizu M, Iida K. Glucosamine Inhibits the Proliferation of Hepatocellular Carcinoma Cells by Eliciting Apoptosis, Autophagy, and the Anti-Warburg Effect. Scientifica. 2025; 2025:5685884.","DOI":"10.1155\/sci5\/5685884"},{"key":"2203_CR208","doi-asserted-by":"publisher","first-page":"104","DOI":"10.3390\/medicines6040104","volume":"6","author":"C Sun","year":"2019","unstructured":"Sun C, Chesnokov V, Larson G, Itakura K. Glucosamine enhances TRAIL-induced apoptosis in the prostate cancer cell line DU145. Medicines. 2019;6:104.","journal-title":"Medicines"},{"key":"2203_CR209","doi-asserted-by":"crossref","unstructured":"Friedman SJ, Skehan P. Membrane-active drugs potentiate the killing of tumor cells by D-glucosamine. Proc Natl Acad Sci. 1980;77:1172\u20136.","DOI":"10.1073\/pnas.77.2.1172"},{"key":"2203_CR210","doi-asserted-by":"crossref","unstructured":"De Queiroz RM, Oliveira IA, Piva B, Bouchuid Cat\u00e3o F, da Costa Rodrigues B, da, Pascoal C et al. A, Hexosamine biosynthetic pathway and glycosylation regulate cell migration in melanoma cells. Frontiers in Oncology. 2019; 9:116.","DOI":"10.3389\/fonc.2019.00116"},{"key":"2203_CR211","doi-asserted-by":"publisher","first-page":"1814","DOI":"10.1194\/jlr.M800343-JLR200","volume":"50","author":"W Qiu","year":"2009","unstructured":"Qiu W, Su Q, Rutledge AC, Zhang J, Adeli K. Glucosamine-induced Endoplasmic reticulum stress attenuates Apolipoprotein B100 synthesis via PERK signaling. J Lipid Res. 2009;50:1814\u201323.","journal-title":"J Lipid Res"},{"key":"2203_CR212","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2407-14-31","volume":"14","author":"K-H Song","year":"2014","unstructured":"Song K-H, Kang J-H, Woo J-K, Nam J-S, Min H-Y, Lee H-Y, et al. The novel IGF-IR\/Akt\u2013dependent anticancer activities of glucosamine. BMC Cancer. 2014;14:1\u201312.","journal-title":"BMC Cancer"},{"key":"2203_CR213","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1475-2867-9-25","volume":"9","author":"V Chesnokov","year":"2009","unstructured":"Chesnokov V, Sun C, Itakura K. Glucosamine suppresses proliferation of human prostate carcinoma DU145 cells through Inhibition of STAT3 signaling. Cancer Cell Int. 2009;9:1\u201311.","journal-title":"Cancer Cell Int"},{"key":"2203_CR214","doi-asserted-by":"publisher","first-page":"e0200757","DOI":"10.1371\/journal.pone.0200757","volume":"13","author":"J Bo\u017ei\u010d","year":"2018","unstructured":"Bo\u017ei\u010d J, Stoka V, Dolenc I. Glucosamine prevents polarization of cytotoxic granules in NK-92 cells by disturbing FOXO1\/ERK\/paxillin phosphorylation. PLoS ONE. 2018;13:e0200757.","journal-title":"PLoS ONE"}],"container-title":["Inflammation Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00011-026-02203-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00011-026-02203-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00011-026-02203-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T00:04:38Z","timestamp":1773792278000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00011-026-02203-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,17]]},"references-count":214,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2203"],"URL":"https:\/\/doi.org\/10.1007\/s00011-026-02203-y","relation":{},"ISSN":["1420-908X"],"issn-type":[{"value":"1420-908X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,17]]},"assertion":[{"value":"24 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"53"}}